In contrast, in a pancreatic cancer model using mice transgenic for αSMA thymidine kinase, elimination of αSMA myofibroblasts resulted in more aggressive tumors and decreased animal survival (Özdemir et al., 2014). This evidence concerns the gene ACTA1 and pancreatic neoplasm.